How to Calculate Extracellular Volume Fraction (ECV)
ECV is calculated using pre- and post-contrast T1 mapping values from both myocardium and blood pool, combined with the patient's hematocrit, using a standardized formula that accounts for the partition coefficient of gadolinium between blood and myocardial tissue.
The Standard ECV Calculation Formula
The conventional method requires:
- Native (pre-contrast) T1 values of myocardium and blood
- Post-contrast T1 values of myocardium and blood
- Hematocrit (measured from blood sample)
The formula is:
ECV = (1 - Hematocrit) × (ΔR1 myocardium / ΔR1 blood)
Where:
- ΔR1 = change in R1 relaxation rate (R1 = 1/T1)
- ΔR1 myocardium = (1/T1 post-contrast myocardium) - (1/T1 native myocardium)
- ΔR1 blood = (1/T1 post-contrast blood) - (1/T1 native blood)
Clinical Context and Interpretation
ECV quantifies the extracellular space expansion in myocardium, detecting diffuse processes like edema and fibrosis that may be missed by late gadolinium enhancement (LGE) alone 1. In chronic myocardial infarction, ECV values are markedly elevated—up to double normal myocardium—and correlate strongly with LGE but provide more quantitative information 2.
Key Technical Requirements
Critical timing considerations 2:
- Proper delay after contrast injection is crucial
- ECV measurements require published or local normal reference values
- Scanner-specific calibration is essential
Alternative Method: Synthetic ECV (Without Blood Sampling)
For clinical settings where hematocrit sampling is impractical, synthetic ECV can be calculated using only blood pool T1 values, eliminating the need for blood draws 3, 4.
Synthetic Hematocrit Calculation
The most accurate model uses a reciprocal formula incorporating both native and post-contrast blood T1 values 5:
Synthetic Hematocrit = -0.047 + (779/T1 blood native) - (11.36/T1 blood post-contrast)
Alternative linear model 4: Synthetic Hematocrit = 628.5 × R1 - 0.002 (where R1 = 1/blood pool T1)
Performance of Synthetic ECV
Synthetic ECV demonstrates:
- High agreement with conventional ECV (R² = 0.88-0.89) 3
- Mean difference of only 0.007% with limits of agreement -4.32% to 4.33% 4
- Equivalent clinical utility for risk stratification and outcome prediction 3, 4
Important caveat: Specific models perform better in anemia patients (bias reduced from -2.45% to -1.28%), while common models are simpler for routine practice 3.
Clinical Applications
ECV serves as a powerful prognostic marker 6, 7:
- Predicts all-cause mortality (adjusted HR 1.91) and heart failure (adjusted HR 1.94) in coronary artery disease patients 6
- Elevated ECV (>median of 28.23%) independently predicts composite adverse outcomes 6
- Can detect reversible myocardial injury in conditions like Takotsubo cardiomyopathy 8
Diagnostic Role
ECV is particularly valuable when 1, 2:
- LGE is negative but clinical suspicion for myocardial disease remains
- Assessing diffuse fibrosis or global edema
- Differentiating acute from chronic processes (when combined with T2 mapping)
- Gadolinium administration should be avoided (use synthetic ECV)
Practical Implementation Algorithm
- Acquire T1 maps: Native and post-contrast (typically 15-20 minutes post-gadolinium)
- Measure T1 values: Place regions of interest in myocardium and blood pool (avoid areas of obvious LGE)
- Obtain hematocrit: Either from blood sample OR calculate synthetic hematocrit from blood pool T1
- Apply formula: Use standard or synthetic ECV calculation
- Compare to reference values: Use scanner-specific normal ranges (typically 25-28% for normal myocardium)
Common pitfall: ECV values are scanner-dependent and vary with field strength (1.5T vs 3.0T), pulse sequences, and timing 2. Always use locally validated reference ranges rather than published cutoffs from different centers.